Brian M. Stolz's Insider Trades & SAST Disclosures

Brian M. Stolz's most recent trade in BridgeBio Pharma Inc was a trade of 1,595 Restricted Stock Units done . Disclosure was reported to the exchange on Aug. 16, 2020.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
BridgeBio Pharma Inc
Brian M. Stolz Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Aug 2020 1,595 23,937 - - Restricted Stock Units
BridgeBio Pharma Inc
Brian M. Stolz Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Aug 2020 1,595 25,167 (0%) 0% - Common Stock
BridgeBio Pharma Inc
Brian M. Stolz Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.53 per share. 16 Aug 2020 552 24,615 (0%) 0% 28.5 15,749 Common Stock
BridgeBio Pharma Inc
Brian M. Stolz Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2020 183,727 183,727 - - Stock Option (Right to Buy)
BridgeBio Pharma Inc
Brian M. Stolz Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2020 25,532 25,532 - - Restricted Stock Units
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades